528-P: The Effect of Angiotensin II (ANG II) Infusion on Plasma Uric Acid (PUA) in Patients with Type 1 Diabetes (T1D)
Yuliya Lytvyn(University Health Network), David Cherney, Leif Erik Lovblom(Mount Sinai Hospital), Hillary A. Keenan(Joslin Diabetes Center), ANDRIY LYTVYN(Toronto General Hospital), Petter Bjornstad(University of Colorado Denver), Alanna Weisman(Mount Sinai Hospital), Alexandra Katz(University of Toronto), Andrew Advani(St. Michael's Hospital), Vera Bril(University Health Network), Julie A. Lovshin(Sunnybrook Health Science Centre), Geneviève Boulet(University of Toronto), Narinder Paul, Bruce A. Perkins(Sinai Health System), Mohammed A. Farooqi(Mount Sinai Hospital), Michael H. Brent(University of Toronto)
Cited by 0
Related Papers
Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study
|Diabetes|2010|497
Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction
|Nature Medicine|2017|493
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470